TITLE

Actos and bladder cancer risk

PUB. DATE
July 2011
SOURCE
Internal Medicine Alert;7/15/2011 Pharmacology Watch, p2
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the warning issued by the U.S. Food and Drug Administration (FDA) concerning the potential risk of bladder cancer associated with the use of the diabetes drug pioglitazone (Actos).
ACCESSION #
65206158

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics